Sarah Rouse is a registered patent attorney focused on identifying, securing, protecting and maximizing the value of clients' intellectual property.
Dr. Rouse concentrates her practice in intellectual property, with a particular focus on patent procurement, patent litigation, portfolio strategy and management, due diligence and client counseling. Her experience includes drafting and prosecuting patent applications and analyzing patentability, validity and infringement matters in areas of technology that include medicinal chemistry, pharmaceuticals, nanoscale drug delivery vehicles, stem cell technology, gene therapy platforms, medical devices and advanced composite materials. In addition, Dr. Rouse has experience in pharmaceutical patent litigation, including ANDA and Hatch-Waxman-based litigation.
Dr. Rouse is co-inventor on issued patents and pending patent applications directed to nanomedicine. In addition, her research led to the formation of Keystone Nano, a Pennsylvania biotech company that partners with health care companies to speed market launch of nano-enabled therapeutics and NanoSpecialties LLC, a joint venture company between Keystone Nano and the Nalco Company (NYSE:NLC) that creates new products with nano-features for industrial markets.
Dr. Rouse provides a wealth of international intellectual property experience. Prior to joining Katten, she was a foreign law consultant at Abreu, Merkl e Advogados Associados in Curitiba, Brazil. She also served as an intern at the World Intellectual Property Organization (WIPO) Coordination Office at the United Nations in New York, NY.
Dr. Rouse previously worked as a patent attorney at a large Philadelphia-based firm and as a patent agent/technical specialist with a patent boutique in Chicago.
Publications and Presentations
Dr. Rouse is currently a member of the editorial advisory board for the Bureau of National Affairs publication
Life Sciences Law & Industry Report (LSLR) as well as a faculty member of the Certified Patent Valuation Analyst (CPVA) program at the Business Development Academy. She was also recently elected as an alternate councilor for the American Chemical Society Division of Colloid and Surface Chemistry. In addition, Dr. Rouse is the author and co-author of several publications and presentations, a limited selection of which includes:
- "Negotiating Nanotech Licensing Agreements," Patent Valuation Analyst Webinar Course, The Business Development Academy, Princeton, NJ (2011)
- Chapter 4: Patent Prosecution and Litigation, Nanotechnology Commercialization for Managers and Scientists, Escoffier and Helwegen (Editors), Pan Stanford Publishing (2011)
- "Encapsulation of Organic Molecules in Calcium Phosphate Nanocomposite Particles for Intracellular Imaging and Drug Delivery," Nano Letters, 8[12], 4108-4115 (2008)
- "Calcium Phosphate Nanocomposite Particles for In Vitro Imaging and Encapsulated Chemotherapeutic Drug Delivery to Cancer Cells," Nano Letters, 8[12], 4116-4121 (2008)
- Chapter 6: Colloidal Lessons Learned for Dispersion of Nanosize Particulate Suspensions, Lessons in Nanotechnology from Traditional and Advanced Ceramics, Baumard (Editor), Techna Group Srl (2005)
Education and Bar Admissions
Dr. Rouse received dual undergraduate degrees in metallurgical engineering and chemistry from the South Dakota School of Mines and Technology and her Ph.D. in materials science and engineering from The Pennsylvania State University. Her doctoral research focused on the synthesis, dispersion and characterization of nanocomposite particles for nanomedical applications including bioimaging, drug delivery and gene therapy. While at Penn State, Dr. Rouse was named as a National Science Foundation Fellow. She received her J.D. and certificate in intellectual property law from the DePaul University College of Law.